Stock listing
CSE:MDMA PharmAla Biotech Holdings, Inc. Stock
Home listing (CSE) of PharmAla Biotech Holdings, Inc.
Follow PharmAla Biotech Holdings, Inc. into a list and get an email when it puts out news.
Share price · CSE:MDMA
$0.185 CAD +0.015 (+8.8%)
Close on Nov 2, 2026
- Day range
- $0.175 – $0.190 CADNov 2, 2026
- Volume
- 28,913 sharesNov 2, 2026
- Market cap
- $20.38M CADAt the close on Nov 2, 2026 · price × 110.2M shares outstanding
- 52-week range
- $0.085 – $0.330 CADLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $44,177 CADMedian day 110,700 shares · last 3 months, Aug 4, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| CSE:MDMA · Home | $0.185 CAD | +0.015 (+8.8%) | 28,913 | $0.180 | $0.190 | $0.175 | $0.170 | Close on Nov 2, 2026 |
| OTC:MDXXF | $0.121 USD | -0.008 (-6.1%) | 751 | $0.121 | $0.121 | $0.121 | $0.129 | Close on Oct 22, 2026 |
Daily closes
Last 3 months, Aug 4, 2026 – Nov 2, 2026 · CSE:MDMA · CAD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.185 | +0.015 | +8.8% | $0.180 | $0.190 | $0.175 | 28,913 | |
| $0.170 | +0.010 | +6.3% | $0.160 | $0.170 | $0.160 | 13,653 | |
| $0.160 | 0.000 | 0.0% | $0.160 | $0.175 | $0.155 | 43,857 | |
| $0.160 | -0.005 | -3.0% | $0.165 | $0.165 | $0.160 | 3,550 | |
| $0.165 | 0.000 | 0.0% | $0.165 | $0.170 | $0.155 | 64,000 | |
| $0.165 | +0.005 | +3.1% | $0.185 | $0.185 | $0.155 | 11,159 | |
| $0.160 | -0.005 | -3.0% | $0.165 | $0.225 | $0.160 | 28,656 | |
| $0.165 | -0.015 | -8.3% | $0.185 | $0.185 | $0.155 | 138,293 | |
| $0.180 | +0.005 | +2.9% | $0.170 | $0.180 | $0.170 | 38,100 | |
| $0.175 | +0.015 | +9.4% | $0.160 | $0.180 | $0.160 | 93,892 | |
| $0.160 | +0.005 | +3.2% | $0.170 | $0.170 | $0.160 | 34,091 | |
| $0.155 | -0.025 | -13.9% | $0.190 | $0.190 | $0.155 | 384,012 | |
| $0.180 | -0.020 | -10.0% | $0.205 | $0.205 | $0.180 | 220,162 | |
| $0.200 | 0.000 | 0.0% | $0.210 | $0.210 | $0.190 | 28,496 | |
| $0.200 | -0.015 | -7.0% | $0.210 | $0.210 | $0.175 | 156,416 | |
| $0.215 | +0.005 | +2.4% | $0.210 | $0.215 | $0.205 | 51,297 | |
| $0.210 | -0.015 | -6.7% | $0.220 | $0.225 | $0.200 | 122,185 | |
| $0.225 | -0.020 | -8.2% | $0.250 | $0.250 | $0.220 | 146,986 | |
| $0.245 | 0.000 | 0.0% | $0.250 | $0.255 | $0.245 | 16,092 | |
| $0.245 | 0.000 | 0.0% | $0.245 | $0.255 | $0.245 | 98,947 | |
| $0.245 | +0.015 | +6.5% | $0.235 | $0.245 | $0.225 | 36,622 | |
| $0.230 | +0.005 | +2.2% | $0.225 | $0.230 | $0.225 | 7,925 | |
| $0.225 | +0.005 | +2.3% | $0.215 | $0.230 | $0.215 | 11,522 | |
| $0.220 | -0.005 | -2.2% | $0.220 | $0.235 | $0.215 | 77,788 | |
| $0.225 | -0.005 | -2.2% | $0.215 | $0.235 | $0.215 | 30,174 | |
| $0.230 | -0.015 | -6.1% | $0.240 | $0.240 | $0.220 | 154,381 | |
| $0.245 | 0.000 | 0.0% | $0.245 | $0.255 | $0.230 | 67,390 | |
| $0.245 | +0.010 | +4.3% | $0.245 | $0.245 | $0.210 | 223,699 | |
| $0.235 | -0.025 | -9.6% | $0.265 | $0.265 | $0.235 | 111,660 | |
| $0.260 | -0.005 | -1.9% | $0.255 | $0.265 | $0.255 | 38,679 | |
| $0.265 | 0.000 | 0.0% | $0.265 | $0.270 | $0.260 | 41,199 | |
| $0.265 | +0.015 | +6.0% | $0.270 | $0.270 | $0.260 | 68,428 | |
| $0.250 | +0.005 | +2.0% | $0.250 | $0.255 | $0.240 | 141,751 | |
| $0.245 | -0.060 | -19.7% | $0.290 | $0.300 | $0.245 | 831,657 | |
| $0.305 | -0.020 | -6.2% | $0.310 | $0.315 | $0.300 | 113,776 | |
| $0.325 | +0.005 | +1.6% | $0.325 | $0.325 | $0.310 | 361,591 | |
| $0.320 | +0.045 | +16.4% | $0.285 | $0.330 | $0.285 | 1,013,911 | |
| $0.275 | +0.010 | +3.8% | $0.260 | $0.285 | $0.260 | 572,831 | |
| $0.265 | +0.030 | +12.8% | $0.260 | $0.265 | $0.245 | 87,839 | |
| $0.235 | +0.010 | +4.4% | $0.240 | $0.250 | $0.235 | 189,322 | |
| $0.225 | -0.010 | -4.3% | $0.240 | $0.240 | $0.225 | 45,654 | |
| $0.235 | +0.005 | +2.2% | $0.230 | $0.235 | $0.230 | 51,114 | |
| $0.230 | +0.005 | +2.2% | $0.225 | $0.235 | $0.225 | 29,555 | |
| $0.225 | -0.005 | -2.2% | $0.230 | $0.230 | $0.225 | 134,866 | |
| $0.230 | -0.010 | -4.2% | $0.240 | $0.260 | $0.220 | 150,305 | |
| $0.240 | -0.010 | -4.0% | $0.260 | $0.260 | $0.240 | 128,409 | |
| $0.250 | -0.005 | -2.0% | $0.265 | $0.270 | $0.245 | 335,160 | |
| $0.255 | -0.005 | -1.9% | $0.255 | $0.265 | $0.250 | 183,673 | |
| $0.260 | -0.005 | -1.9% | $0.270 | $0.275 | $0.245 | 265,968 | |
| $0.265 | +0.035 | +15.2% | $0.250 | $0.290 | $0.245 | 824,870 | |
| $0.230 | +0.015 | +7.0% | $0.225 | $0.240 | $0.215 | 357,949 | |
| $0.215 | +0.030 | +16.2% | $0.195 | $0.230 | $0.195 | 594,367 | |
| $0.185 | -0.005 | -2.6% | $0.195 | $0.195 | $0.180 | 79,550 | |
| $0.190 | +0.005 | +2.7% | $0.185 | $0.200 | $0.180 | 199,853 | |
| $0.185 | -0.020 | -9.8% | $0.205 | $0.210 | $0.180 | 415,511 | |
| $0.205 | +0.035 | +20.6% | $0.170 | $0.225 | $0.170 | 1,269,522 | |
| $0.170 | +0.005 | +3.0% | $0.165 | $0.175 | $0.160 | 139,256 | |
| $0.165 | +0.010 | +6.5% | $0.160 | $0.170 | $0.160 | 437,629 | |
| $0.155 | +0.015 | +10.7% | $0.140 | $0.160 | $0.135 | 288,913 | |
| $0.140 | -0.010 | -6.7% | $0.145 | $0.150 | $0.140 | 79,019 | |
| $0.150 | 0.000 | 0.0% | $0.150 | $0.150 | $0.145 | 12,846 | |
| $0.150 | 0.000 | 0.0% | $0.150 | $0.150 | $0.145 | 8,543 | |
| $0.150 | -0.005 | -3.2% | $0.150 | $0.155 | $0.150 | 110,700 |
- Ticker
- CSE:MDMA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- CSE
- Currency
- CAD
What changed lately
Latest news release · Oct 8, 2026
Rua Bioscience and PharmAla Biotech partner to supply medicinal MDMA in New Zealand
Latest news
Rua Bioscience and PharmAla Biotech partner to supply medicinal MDMA in New Zealand
Oct 8, 2026
Closed $0.215 (+2.4%) on Oct 9, 2026
PharmAla Biotech Provides Corporate Update, Change of Auditor, Retention of Watertower Research and Oak Hill
Sep 18, 2026
Closed $0.265 (0.0%) on Sep 18, 2026
PharmAla Biotech Provides Corporate Update: U.S. Patent Granted Covering Novel Enantioselective Processes, Decision on APA-01, and Engagement of Canaccord Genuity as Exclusive Investment Banking Partner
Aug 21, 2026
Closed $0.265 (+15.2%) on Aug 21, 2026
PharmAla Issues Q3 Financial Statements and AGM Update
Jul 30, 2026
Closed $0.16 (+6.7%) on Jul 30, 2026
PharmAla Biotech Executes Definitive License Agreement Granting Jupiter Neurosciences Exclusive U.S. Rights to ALA-002
Jul 21, 2026
Closed $0.15 (-3.2%) on Jul 21, 2026
PharmAla Completes GMP Manufacturing of Drug Substance components for ALA-002 Provides Corporate Update Regarding ALA-002 Asset
Jul 6, 2026
Closed $0.145 (+3.6%) on Jul 6, 2026
PharmAla Biotech Signs Term Sheet to License Exclusive U.S. Rights to ALA-002, Its Next-Generation MDMA Therapeutic, to Jupiter Neurosciences, Inc. (NASDAQ: JUNS) in a Transaction Valued at Over $100 Million
May 20, 2026
Closed $0.165 (+10.0%) on May 20, 2026
PharmAla Biotech Executes Definitive Agreement to Form Special Purpose Vehicle, Restora Neurosciences, for Clinical Development of Patented Novel MDXX Molecule APA-01
May 13, 2026
Closed $0.15 (+7.1%) on May 13, 2026
PharmAla Executes Binding Letter of Intent for Formation of Special Purpose Vehicle to Develop Patented Novel MDXX Molecule APA-01
Apr 27, 2026
Closed $0.165 (+13.8%) on Apr 27, 2026
PharmAla Issues Q2 Financial Statements and Grants Options
Apr 21, 2026
Closed $0.16 (+3.2%) on Apr 22, 2026
PharmAla Biotech Holdings, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 20 in the last 12 months · 40 in all · newest Oct 8, 2026 · oldest 2023
Where PharmAla Biotech Holdings, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| CSE:MDMA · Home listing · This page | CSE | Canada | CAD |
| OTC:MDXXF | OTC | United States | USD |
| Cboe Canada:MDMA | Cboe Canada | Canada | CAD |
Log in to ask 6ix AI your own questions about PharmAla Biotech Holdings, Inc.